The secondary-developmental-myxomas exhibited this reactivity in 3 of 4 cases as demonstrated in Figs. 3 and 4 of Peter’s anomaly cases, while the secondary-truly acquired-myxomas showed reactivity with SMA antibodies in a single case of keratitis (1/4). This evidence concerns the gene SMN1 and myxoma.